HT
ESPR

Headlands Technologies’s Esperion Therapeutics ESPR Stock Holding History

Headlands Technologies’s Portfolio ESPR Stock Details ESPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$38.8K Sell
14,157
-206,931
-94% -$655K ﹤0.01% 705
2025
Q4 		$818K Buy
221,088
+124,830
+130% +$403K 0.07% 300
2025
Q3 		$255K Buy
+96,258
New +$186K 0.02% 500
2025
Q2 		– Sell
-38,447
Closed -$55.4K – 1287
2025
Q1 		$55.4K Sell
38,447
-216,619
-85% -$399K 0.01% 696
2024
Q4 		$561K Buy
255,066
+90,522
+55% +$211K 0.06% 324
2024
Q3 		$271K Sell
164,544
-111,716
-40% -$226K 0.03% 450
2024
Q2 		$613K Buy
+276,260
New +$650K 0.07% 242
2024
Q1 		– Sell
-3,208
Closed -$9.59K – 1323
2023
Q4 		$9.59K Buy
+3,208
New +$4.16K ﹤0.01% 762
2023
Q3 		– Sell
-2,110
Closed -$2.93K – 1009
2023
Q2 		$2.93K Buy
+2,110
New +$2.95K ﹤0.01% 704

Other funds holding ESPR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return